2001
DOI: 10.1016/s0165-022x(01)00212-3
|View full text |Cite
|
Sign up to set email alerts
|

Identification of model peptides as affinity ligands for the purification of humanized monoclonal antibodies by means of phage display

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(18 citation statements)
references
References 21 publications
1
17
0
Order By: Relevance
“…This result corroborates the powerful application of the PD technology in selecting peptide ligands [20], especially against monoclonal antibodies [21], which has also proven to be an effective strategy for vaccine development [22] and drug discovery [23]. The mimotopes have strongly bound to the mAb anti-MSP1 with reactivities that were superior to the peptide that were synthetized based on the native MSP1a sequence as demonstrated by ELISA assays.…”
Section: Discussionsupporting
confidence: 71%
“…This result corroborates the powerful application of the PD technology in selecting peptide ligands [20], especially against monoclonal antibodies [21], which has also proven to be an effective strategy for vaccine development [22] and drug discovery [23]. The mimotopes have strongly bound to the mAb anti-MSP1 with reactivities that were superior to the peptide that were synthetized based on the native MSP1a sequence as demonstrated by ELISA assays.…”
Section: Discussionsupporting
confidence: 71%
“…34,69-72 Moreover, increased number of injection cycles is not a concern because our results proved that the m-NBST column retained its function without any loss in its performance even after 200 injections. This is a significantly high number compared to any protein based column, especially considering that most of the protein based affinity columns start showing signs of degradation after just 10 cycles of injections, and require cleaning cycles regularly.…”
Section: Resultsmentioning
confidence: 57%
“…With the rapid development of the technique over the past decade, phage display has been used successfully in numerous applications, including antibody engineering [14], peptide and protein drug discovery and manufacture [15], vaccine development [16] and identification of ligands [17]. Phage display screen has been reported against whole cells as well as against whole viruses [18],[19].…”
Section: Discussionmentioning
confidence: 99%